Shopping Cart
- Remove All
- Your shopping cart is currently empty
Eluvixtamab (AMG-330) is a bispecific T-cell engager targeting CD33. It recognizes a linear epitope within the CD33 V-set domain, with a core sequence of IPYYDKN. By binding to CD33 on AML cells and CD3 on T cells, Eluvixtamab facilitates the destruction of CD33+ cells by T cells.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | Inquiry | Inquiry | |
5 mg | Inquiry | Inquiry |
Description | Eluvixtamab (AMG-330) is a bispecific T-cell engager targeting CD33. It recognizes a linear epitope within the CD33 V-set domain, with a core sequence of IPYYDKN. By binding to CD33 on AML cells and CD3 on T cells, Eluvixtamab facilitates the destruction of CD33+ cells by T cells. |
Alias | MT-114, AMG-330 |
Cas No. | 1679391-73-1 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.